Depending on the peptide, they may support areas such as recovery, body composition, energy, sleep, skin health, cognitive performance, immune balance, or healthy aging
optional extension to 16 weeks
Anaemia, megaloblastic treatment summary
The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
IV NAD+ therapy delivers NAD directly into the bloodstream, bypassing the digestive system and achieving blood concentrations that oral supplements cannot reliably reach
Barrier vs InfiniWell at a glance Barrier BPC-GI Technology: proprietary precision-pressed tablet Why it is plausible Local exposure matches its gut-focused positioning